In the News
Spotlighting our presentations at the Precision Medicine World Conference 2023
Kicking off the new year, the annual Precision Medicine World Conference (PMWC) took place in-person at the Santa Clara Convention Center in Santa Clara, California
Mars Petcare And Diversigen Collaborate In One Of The Largest Ever Microbiome Studies To Evaluate Pet Health
OraSure Partners with Mars Petcare in One of the Largest Ever Microbiome Studies to Evaluate Pet Health BETHLEHEM, Pa., September 14, 2022 (Globe Newswire) –
Prolacta Bioscience publishes new research showing reversible engraftment using a synbiotic of B. infantis and HMO in healthy adult microbiomes without antibiotics
Prolacta Bioscience has published new research successfully using a synbiotic of human milk oligosaccharides (HMOs) with Bifidobacterium longum subsp. infantis (B. infantis) to reversibly engraft
Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board
Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board Joins Diversigen’s Scientific Advisory Board Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific
Former CEO of H2O+ Beauty, Former Chief Chemist of MAC Cosmetics Launch Innovative Skincare Brand Using First-Ever Scientific Microbiome Testing
Pure Culture Beauty delivers a clean, customized skincare regimen formulated to enhance consumers’ skin health SAN FRANCISCO, Sept. 15, 2020 (GLOBE NEWSWIRE) — Today, Joy
Diversigen, Inc. and Alimentiv Inc. Announce Collaboration Agreement for Ulcerative Colitis Research Study
ST. PAUL, MN, June 25, 2020 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Alimentiv Inc. (formerly Robarts Clinical Trials) today announced